Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015.

Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill. 2015 Dec 10;20(49) Authors: Chu DK, Oladipo JO, Perera RA, Kuranga SA, Chan SM, Poon LL, Peiris M Abstract Evidence of current and past Middle East respiratory syndrome coronavirus (MERS-CoV) infection in dromedary camels slaughtered at an abattoir in Kano, Nigeria in January 2015, was sought by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and serology. MERS-CoV RNA was detected in 14 (11%) of 132 nasal swabs and antibody in 126 (96%) of 131 serum samples. Phylogenetic analyses demonstrate that the viruses in Nigeria are genetically distinct from those reported in the Arabian peninsula. PMID: 26676406 [PubMed - in process]
Source: Euro Surveill - Category: Infectious Diseases Authors: Tags: Euro Surveill Source Type: research

Related Links:

R. Harvey et al.
Source: Emerging Infectious Diseases Journal - Category: Infectious Diseases Source Type: research
N. Okba et al.
Source: Emerging Infectious Diseases Journal - Category: Infectious Diseases Source Type: research
Outbreaks of severe acute respiratory syndrome (SARS) in 2002, Middle East respiratory syndrome in 2012 and fatal swine acute diarrhea syndrome in 2017 caused serious infectious diseases in humans and in livestock, resulting in serious public health threats and huge economic losses. All such coronaviruses (CoVs) were confirmed to originate from bats. To continuously monitor the epidemic-related CoVs in bats, virome analysis was used to classify CoVs from 831 bats of 15 species in Yunnan, Guangxi, and Sichuan Provinces between August 2016 and May 2017. We identified 11 CoV strains from 22 individual samples of four bat spec...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
AbstractWith reports of vancomycin-resistant enterococci recently emerging in hospital settings, renewed focus is turning to the importance of multifaceted infection prevention efforts. Careful compliance with established hygiene practices by healthcare workers together with effective antiseptic options is essential for the protection of patients from infectious agents. For over 60  years, povidone iodine (PVP-I) formulations have been shown to limit the impact and spread of infectious diseases with potent antiviral, antibacterial and antifungal effects. In addition to a lack of reported resistance, the benefits of PV...
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
Perera Chu Hassan Elsokary Saad Sobhy El Masry McKenzie Webby Peiris Makonnen Ali Kayali : Dromedary camels are the natural reservoirs of the Middle East respiratory syndrome coronavirus (MERS-CoV). Camels are mostly bred in East African countries then exported into Africa and Middle East for consumption. To understand the distribution of MERS-CoV among camels in North Africa and the Middle East, we conducted surveillance in Egypt, Senegal, Tunisia, Uganda, Jordan, Saudi Arabia, and Iraq. We also performed longitudinal studies of three camel herds in Egypt and Jordan to elucidate ME...
Source: Viruses - Category: Virology Authors: Tags: Article Source Type: research
Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven effective against this viral disease. In addition, no vaccine has been licensed to prevent MERS-CoV thus far. Therefore, our current review focuses on the most recent studies in search of an effective MERS vaccine. Overall, vaccine candidates against MERS-CoV are mainly based upon the viral spike (S) protein, due to its vital role in the viral infectivity, although several studies focused on other viral proteins such as the nucleocapsid (N) protein, en...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Authors: Mustafa S, Balkhy H, Gabere M Abstract There is no effective therapeutic or vaccine for Middle East Respiratory Syndrome and this study attempts to find therapy using peptide by establishing a basis for the peptide-protein interactions through in silico docking studies for the spike protein of MERS-CoV. The antimicrobial peptides (AMPs) were retrieved from the antimicrobial peptide database (APD3) and shortlisted based on certain important physicochemical properties. The binding mode of the shortlisted peptides was measured based on the number of clusters which forms in a protein-peptide docking using Pipe...
Source: Advances in Bioinformatics - Category: Bioinformatics Tags: Adv Bioinformatics Source Type: research
Type 1 IFNs (IFN-I) generally protect mammalian hosts from virus infections, but in some cases, IFN-I is pathogenic. Because IFN-I is protective, it is commonly used to treat virus infections for which no specific approved drug or vaccine is available. The Middle East respiratory syndrome–coronavirus (MERS-CoV) is such an infection, yet little is known about the role of IFN-I in this setting. Here, we show that IFN-I signaling is protective during MERS-CoV infection. Blocking IFN-I signaling resulted in delayed virus clearance, enhanced neutrophil infiltration, and impaired MERS-CoV–specific T cell responses. N...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
(Walter Reed Army Institute of Research) The Walter Reed Army Institute of Research conducted a Phase 1 first-in-human trial of a Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate that was shown to be safe, well-tolerated, and induced a robust immune response comparable to response seen in survivors of natural MERS CoV infection. Initial findings were published today in The Lancet Infectious Diseases and have prompted further trials of the vaccine co-developed by GeneOne Life Science Inc. and Inovio Pharmaceuticals.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
From 1 through 30 June 2019, the National International Health Regulations (IHR) Focal Point of Saudi Arabia reported 7 additional cases of Middle East respiratory syndrome (MERS-CoV) infection. These cases were from Al-Qassim (3 cases), Riyadh (2 cases), Madinah (1 death) and Eastern (1 case) regions. One of the newly reported cases is a health care worker, contact of a case included in the Disease outbreak news published on16 July 2019(Case no. 14). Two deaths were reported, one (Case no. 5) from the current reporting month, and a second death (Case no. 13) previously described as a case in the Disease outbreak news on16...
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
More News: Coronavirus | Genetics | Infectious Diseases | MERS | Middle East Health | Respiratory Medicine